Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia

NCT02838316 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Oropharyngeal Dysphagia

Interventions

DRUG: Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR)

Sponsor

Peter Belafsky, MD

Collaborators

[object Object]